|28.79||-0.2300||-0.79%||Vol 1.11M||1Y Perf 174.10%|
|Apr 13th, 2021 16:00 DELAYED|
|- -||-0.41 -1.42%|
|Target Price||26.25||Analyst Rating||Hold 2.60|
|Potential %||-8.82||Finscreener Ranking||★★ 46.63|
|Insiders Trans % 3/6/12 mo.||-/-100/-11||Value Ranking||★★★+ 53.47|
|Insiders Value % 3/6/12 mo.||-/-100/-98||Growth Ranking||★+ 43.02|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-95||Income Ranking||★★★+ 49.42|
|Market Cap||4.76B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||97.18||Earnings Date||4th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th May 2021|
|Estimated EPS Next Report||0.68|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.15M|
|Avg. Monthly Volume||1.42M|
|Avg. Quarterly Volume||1.56M|
Chemours Company (The) (NYSE: CC) stock closed at 28.79 per share at the end of the most recent trading day (a -0.79% change compared to the prior day closing price) with a volume of 1.19M shares and market capitalization of 4.76B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Chemicals industry, Basic Materials sector and employs 6500 people. Chemours Company (The) CEO is Mark P. Vergnano.
The one-year performance of Chemours Company (The) stock is 174.1%, while year-to-date (YTD) performance is 16.14%. CC stock has a five-year performance of 281.98%. Its 52-week range is between 8.83 and 29.37, which gives CC stock a 52-week price range ratio of 97.18%
Chemours Company (The) currently has a PE ratio of 20.60, a price-to-book (PB) ratio of 5.57, a price-to-sale (PS) ratio of 1.31, a price to cashflow ratio of 5.70, a PEG ratio of 2.32, a ROA of 2.92%, a ROC of 0.72% and a ROE of 28.02%. The company’s profit margin is 3.07%, its EBITDA margin is 4.70%, and its revenue ttm is $3.66 Billion , which makes it $22.18 revenue per share.
Of the last four earnings reports from Chemours Company (The), there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.68 for the next earnings report. Chemours Company (The)’s next earnings report date is 04th May 2021.
The consensus rating of Wall Street analysts for Chemours Company (The) is Hold (2.6), with a target price of $26.25, which is -8.82% compared to the current price. The earnings rating for Chemours Company (The) stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Chemours Company (The) has a dividend yield of 3.45% with a dividend per share of $1.00 and a payout ratio of 41.00%.
Chemours Company (The) has a Buy technical analysis rating based on Technical Indicators (ADX : 11.24, ATR14 : 1.30, CCI20 : 96.73, Chaikin Money Flow : 0.14, MACD : 0.31, Money Flow Index : 56.06, ROC : 9.51, RSI : 53.70, STOCH (14,3) : 88.91, STOCH RSI : 0.52, UO : 57.34, Williams %R : -11.09), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Chemours Company (The) in the last 12-months were: E. Bryan Snell (Option Excercise at a value of $878 004), E. Bryan Snell (Sold 56 682 shares of value $1 263 442 ), Edwin C. Sparks (Option Excercise at a value of $84 513), Edwin C. Sparks (Sold 5 456 shares of value $112 175 ), Mark E. Newman (Buy at a value of $58 097), Mark P. Vergnano (Option Excercise at a value of $2 375 597), Mark P. Vergnano (Sold 153 392 shares of value $4 184 963 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.